Israeli Biotech Firm Produces New Drug for Gaucher's Disease.
<![CDATA[ An Israeli firm has passed the first hurdle in gaining FDA approval for a new treatment for Gaucher's disease.]]>
To see the full article, click here: http://www.israelnationalnews.com/News/News.aspx/134915
 Printer friendly
 Cite/link
 Email
 Feedback
| |
| Title Annotation: | Protalix Biotherapeutics Inc.'s taliglucerase alfa |
|---|---|
| Publication: | Arutz Sheva/Israel National News (Beit El, Israel) |
| Geographic Code: | 7ISRA |
| Date: | Dec 10, 2009 |
| Words: | 84 |
| Previous Article: | Court: Visiting Jailed Terrorists not an Overriding Need. |
| Next Article: | Israeli Envoy to US X-s Out J Street. |
| Topics: | |